Table:
begin	end	state
1	22	cytoplasmic
23	41	transmembrane
42	46	non-cytoplasmic
47	65	transmembrane
66	72	cytoplasmic
73	91	transmembrane
92	105	non-cytoplasmic
106	126	transmembrane
127	132	cytoplasmic
133	151	transmembrane
152	189	non-cytoplasmic
190	209	transmembrane
210	239	cytoplasmic
240	263	transmembrane
264	274	non-cytoplasmic
275	302	transmembrane
303	322	cytoplasmic
323	343	transmembrane
344	366	non-cytoplasmic

Input:
>WP_034278233.1 NCBI__GCF_000504245.1:WP_034278233.1
MSGRPGLYTSYAQHLRLLNTRPKLVAVGAIVLLALAMPWLVQDRTLSLLALACAASIGAI
GLNIVTGYAGQVSLGHAFFLAIGAYTAAALSGDPDGRTIGFGVTNVLVWLLAAGLVAAVF
GVLVAPLATRLRGLYLAIVTLGLVFIGEHVFKEWRDLTGGAGVGRPGPVPELFGVTLNKS
GDVLTSDQKLYLLMLVCLVVLGILARNLARSKVGRAFAAIRDRDIAASVIGVNLARYKMI
AFAVSSFYAGCAGALLYTITGFIEPTSFNLLLSVQYIAMVLIGGVATISGSIMGAFFITL
LPALTRELPTVAPFISSDASAPLNVFQVETVLYGLLIIGFLIFEPRGLYGIWTRIRNYWK
AWPFSY

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server